Improving the lives of patients is at the HEART of what we do.
At Biotherapy Services, we are striving to develop a regenerative and personalised wound healing technology that harnesses the patient’s own ability to treat himself/herself.

Founded in 2013, we are a team of scientists, clinicians, business and health care professionals, with a passion for improving the lives of patients with complex wounds. In developed countries, 1%-2% of the population are estimated to experience a chronic wound at some point in their life, and these numbers are likely to increase with an ageing population.(1) Wounds that don’t heal can lead to severe infections which may subsequently result in amputation. This adds another level of psychological trauma, not just to the amputees but also to their families.


Every day we go to work with the goal of accelerating the development of wound healing technology so we can help as many patients as possible, and as soon as possible.


Making real differences in healthcare is our MISSION

There are 3.5 million people diagnosed with diabetes in the UK,(2) and diabetes is a co-morbidity that underlines chronic wounds. Diabetic foot ulcers is a common complication of diabetes and around 2% of people with diabetes experience new foot ulcers annually, and one in 400 undergoes amputation.(3) The cost of health care for ulceration and amputation in diabetes in 2014–2015 is estimated to be up to £962 million.(4)


Not only do these figures highlight the health issues associated with diabetes in the UK, they also reveal the economic burden on the NHS. It was estimated that 2.2 million wounds was managed by the NHS in 2012/2013 at an annual cost of up to £5.1bn.(5) As demand for health services increases, especially amongst older patients, Biotherapy Services endeavours to help the NHS by:


a/ Raising disease awareness to encourage patients to seek consultation with doctors earlier so their wounds can be treated in early stage to help reduce hospital admission and treatment cost.


b/ Hospital admissions increases 15% from 2010/11 to 2018/19 with most of the growth attributed to older people. The number of overnight beds has decreased from 141, 477 in 2010/11 to 127,225 while average occupancy has risen over this period.(6) Our technology aims to shorten the time of wound treatment. This in turn can help reduce the length of stay in hospitals, release bed days to allow treatment of more patients in need of medical help.


Supporting young talents is our PASSION

We are very proud to be the sponsor for the STEM for BRITAIN 2020 Chemistry Category. We understand nurturing the next generation of UK researchers is vitally important for our UK economy. One of our key members of staff is a past winner of the STEM for BRITAIN Chemistry Award and we look forward to joining Dr ThaoNguyen Nguyen in her return to this prestigious event to support young scientific talents. We are very excited to be a part of STEM for BRITAIN 2020, to inspire and create opportunities for young talents whom we know will be the future of UK innovation and R&D which will have a global impact. 


  1. Järbrink, K.; Ni, G. et al. Systematic Reviews 2016, 5:152 
  3. Kerr, M.; Barron, E.; Jeffcoate, W. Research Article 2018, doi: 10.1111/dme.13973 
  4. Martin, T.; Kyriakides, C.; Sarkar, S. BJS 2015, 102(2), 24. 
  5. Guest, J.F.; Ayoub, N. et al. BMJ Open 2015, 5: e009283 
  6. Insights for the new Parliament, House of Commons Library Publication 2019, 38-39